相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Biomarkers for Alzheimer's disease-preparing for a new era of disease-modifying therapies
Henrik Zetterberg et al.
MOLECULAR PSYCHIATRY (2021)
Towards early disease modification of Parkinson's disease: a review of lessons learned in the Alzheimer field
Marthe Smedinga et al.
JOURNAL OF NEUROLOGY (2021)
Orthostatic Hypotension: A Prodromal Marker of Parkinson's Disease?
Lisanne J. Dommershuijsen et al.
MOVEMENT DISORDERS (2021)
Moving fluid biomarkers for Alzheimer's disease from research tools to routine clinical diagnostics
Henrik Zetterberg et al.
MOLECULAR NEURODEGENERATION (2021)
Parkinson's disease
Bastiaan R. Bloem et al.
LANCET (2021)
Prodromal Parkinson disease subtypes - key to understanding heterogeneity
Daniela Berg et al.
NATURE REVIEWS NEUROLOGY (2021)
Biomarkers and the Role of α-Synuclein in Parkinson's Disease
Tingting Du et al.
FRONTIERS IN AGING NEUROSCIENCE (2021)
Non-Genetic Risk Factors for Parkinson's Disease: An Overview of 46 Systematic Reviews
Yancong Chen et al.
JOURNAL OF PARKINSONS DISEASE (2021)
Improving estimation of Parkinson's disease risk-the enhanced PREDICT-PD algorithm
Jonathan P. Bestwick et al.
NPJ PARKINSONS DISEASE (2021)
Diagnosis and Treatment of Parkinson Disease A Review
Melissa J. Armstrong et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study
Tanya Simuni et al.
LANCET NEUROLOGY (2020)
Modifiable risk and protective factors in disease development, progression and clinical subtypes of Parkinson's disease: What do prospective studies suggest?
Daniele Belvisi et al.
NEUROBIOLOGY OF DISEASE (2020)
A causal framework for classical statistical estimands in failure-time settings with competing events
Jessica G. Young et al.
STATISTICS IN MEDICINE (2020)
Ethnic Variation in the Manifestation of Parkinson's Disease: A Narrative Review
Aaron Ben-Joseph et al.
JOURNAL OF PARKINSONS DISEASE (2020)
Objectives, design and main findings until 2020 from the Rotterdam Study
M. Arfan Ikram et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2020)
Parkinson's disease in the MENASA countries
Hanan Khalil et al.
LANCET NEUROLOGY (2020)
Tobacco smoking and the risk of Parkinson disease: A 65-year follow-up of 30,000 male British doctors
Benjamin Mappin-Kasirer et al.
NEUROLOGY (2020)
How can population-based studies best be utilized to reduce the global impact of dementia? Recommendations for researchers, funders, and policymakers
Blossom C. M. Stephan et al.
ALZHEIMERS & DEMENTIA (2020)
Parkinson's Disease Research on the African Continent: Obstacles and Opportunities
Marieke C. J. Dekker et al.
FRONTIERS IN NEUROLOGY (2020)
Dementia prevention, intervention, and care: 2020 report of the Lancet Commission
Gill Livingston et al.
LANCET (2020)
Brain-first versus body-first Parkinson's disease: a multimodal imaging case-control study
Jacob Horsager et al.
BRAIN (2020)
Application of a Simple Parkinson's Disease Risk Score in a Longitudinal Population-Based Cohort
Kathrin Marini et al.
MOVEMENT DISORDERS (2020)
Clinical and Imaging Progression in thePARSCohort:Long-TermFollow-up
Andrew Siderowf et al.
MOVEMENT DISORDERS (2020)
Twenty-seven-year time trends in dementia incidence in Europe and the United States The Alzheimer Cohorts Consortium
Frank J. Wolters et al.
NEUROLOGY (2020)
Inexpensive, non-invasive biomarkers predict Alzheimer transition using machine learning analysis of the Alzheimer's Disease Neuroimaging (ADNI) database
Juan Felipe Beltran et al.
PLOS ONE (2020)
Parkinson's disease determinants, prediction and gene-environment interactions in the UK Biobank
Benjamin Meir Jacobs et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2020)
Ethical Considerations in Screening for Rapid Eye Movement Sleep Behavior Disorder in the General Population
Lisanne J. Dommershuijsen et al.
MOVEMENT DISORDERS (2020)
Self-Selection Bias: An Essential Design Consideration for Nutrition Trials in Healthy Populations
Lauren M. Young et al.
FRONTIERS IN NUTRITION (2020)
The clinical heterogeneity of Parkinson's disease and its therapeutic implications
Julia C. Greenland et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2019)
The importance of preclinical diagnostics in Parkinson disease
Sneha Mantri et al.
PARKINSONISM & RELATED DISORDERS (2019)
Causal Inference in Environmental Epidemiology: Old and New Approaches
Neil Pearce et al.
EPIDEMIOLOGY (2019)
Prevalence and duration of non-motor symptoms in prodromal Parkinson's disease
R. Durcan et al.
EUROPEAN JOURNAL OF NEUROLOGY (2019)
Combining modifiable risk factors and risk of dementia: a systematic review and meta-analysis
Ruth Peters et al.
BMJ OPEN (2019)
Lifetime risk and multimorbidity of non-communicable diseases and disease-free life expectancy in the general population: A population-based cohort study
Silvan Licher et al.
PLOS MEDICINE (2019)
Biomarkers of Parkinson's disease: 20years later
Rezzak Yilmaz et al.
JOURNAL OF NEURAL TRANSMISSION (2019)
Heterogeneity in progression of prodromal features in Parkinson's disease
A. Schrag et al.
PARKINSONISM & RELATED DISORDERS (2019)
CSF and blood biomarkers for Parkinson's disease
Lucilla Parnetti et al.
LANCET NEUROLOGY (2019)
Bias from self selection and loss to follow-up in prospective cohort studies
Guido Biele et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2019)
Update of the MDS research criteria for prodromal Parkinson's disease
Sebastian Heinzel et al.
MOVEMENT DISORDERS (2019)
Brain-First versus Gut-First Parkinson's Disease: A Hypothesis
Per Borghammer et al.
JOURNAL OF PARKINSONS DISEASE (2019)
The Uncovering Neurodegenerative Insights Through Ethnic Diversity consortium
Hieab H. H. Adams et al.
LANCET NEUROLOGY (2019)
The Parkinson's Disease Mendelian Randomization Research Portal
Alastair J. Noyce et al.
MOVEMENT DISORDERS (2019)
Variation in blood pressure and long-term risk of dementia: A population-based cohort study
Yuan Ma et al.
PLOS MEDICINE (2019)
Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies
Mike A. Nalls et al.
LANCET NEUROLOGY (2019)
Prognosis and Neuropathologic Correlation of Clinical Subtypes of Parkinson Disease
Eduardo De Pablo-Fernandez et al.
JAMA NEUROLOGY (2019)
Emulating a Novel Clinical Trial Using Existing Observational Data Predicting Results of the PreVent Study
Andrew J. Admon et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2019)
Idiopathic REM sleep behaviour disorder and neurodegeneration - an update
Birgit Hoegl et al.
NATURE REVIEWS NEUROLOGY (2018)
Midlife vascular risk factors and midlife cognitive status in relation to prevalence of mild cognitive impairment and dementia in later life: The Atherosclerosis Risk in Communities Study
David S. Knopman et al.
ALZHEIMERS & DEMENTIA (2018)
Plasma urate and risk of Parkinson's disease: A mendelian randomization study
Camilla J. Kobylecki et al.
ANNALS OF NEUROLOGY (2018)
The Rationale Behind the New Alzheimer's Disease Conceptualization: Lessons Learned During the Last Decades
Jose Luis Molinuevo et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Impact of ethnicity on the natural history of Parkinson disease
Anna Sauerbier et al.
MEDICAL JOURNAL OF AUSTRALIA (2018)
Performance of the Movement Disorders Society Criteria for Prodromal Parkinson's Disease: A Population-Based 10-Year Study
Philipp Mahlknecht et al.
MOVEMENT DISORDERS (2018)
Age- and Sex-Related Heterogeneity in Prodromal Parkinson's Disease
Sebastian Heinzel et al.
MOVEMENT DISORDERS (2018)
RBD: a red flag for cognitive impairment in Parkinson's disease?
Yi-Qi Lin et al.
SLEEP MEDICINE (2018)
Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians
Neil M. Davies et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians
Neil M. Davies et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
REM sleep behaviour disorder
Yves Dauvilliers et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
E. Ray Dorsey et al.
LANCET NEUROLOGY (2018)
From Prodromal to Overt Parkinson's Disease: Towards a New Definition in the Year 2040
Daniela Berg et al.
JOURNAL OF PARKINSONS DISEASE (2018)
Parkinson's Disease in Sub-Saharan Africa: A Review of Epidemiology, Genetics and Access to Care
Uduak Williams et al.
JOURNAL OF MOVEMENT DISORDERS (2018)
The value of explicitly emulating a target trial when using real world evidence: an application to colorectal cancer screening
Xabier Garcia-Albeniz et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2017)
Target trial emulation: teaching epidemiology and beyond
Jeremy A. Labrecque et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2017)
Epidemiology of Parkinson's disease
Ole-Bjorn Tysnes et al.
JOURNAL OF NEURAL TRANSMISSION (2017)
LARGE-PD: Examining the Genetics of Parkinson's Disease in Latin America
Cyrus P. Zabetian et al.
MOVEMENT DISORDERS (2017)
Application of the Movement Disorder Society Prodromal Parkinson's Disease Research Criteria in 2 Independent Prospective Cohorts
Andrea Pilotto et al.
MOVEMENT DISORDERS (2017)
Validation of the MDS Research Criteria for Prodromal Parkinson's Disease: Longitudinal Assessment in a REM Sleep Behavior Disorder (RBD) Cohort
Seyed-Mohammad Fereshtehnejad et al.
MOVEMENT DISORDERS (2017)
Past, Present, and Future of Parkinson's Disease: A Special Essay on the 200th Anniversary of the Shaking Palsy
J. A. Obeso et al.
MOVEMENT DISORDERS (2017)
Olfaction and incident Parkinson disease in US white and black older adults
Honglei Chen et al.
NEUROLOGY (2017)
Prodromal Parkinsonism and Neurodegenerative Risk Stratification in REM Sleep Behavior Disorder
Thomas R. Barber et al.
SLEEP (2017)
Global, Yet Incomplete Overview of Cohort Studies in Parkinson's disease
Sebastian Heinzel et al.
JOURNAL OF PARKINSONS DISEASE (2017)
Prodromal Parkinsonism and Neurodegenerative Risk Stratification in REM Sleep Behavior Disorder
Thomas R. Barber et al.
SLEEP (2017)
Natural history of pure autonomic failure: A United States prospective cohort
Horacio Kaufmann et al.
ANNALS OF NEUROLOGY (2017)
Using observational data to emulate a randomized trial of dynamic treatment-switching strategies: an application to antiretroviral therapy
Lauren E. Cain et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2016)
Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available
Miguel A. Hernan et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2016)
Commentary: Should the analysis of observational data always be preceded by specifying a target experimental trial?
Vanessa Didelez
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2016)
Specifying a target trial prevents immortal time bias and other self-inflicted injuries in observational analyses
Miguel A. Hernan et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2016)
The prediagnostic phase of Parkinson's disease
Alastair John Noyce et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)
The epidemiology of Parkinson's disease: risk factors and prevention
Alberto Ascherio et al.
LANCET NEUROLOGY (2016)
Prodromal Parkinson's disease as defined per MDS research criteria in the general elderly community
Philipp Mahlknecht et al.
MOVEMENT DISORDERS (2016)
Advances in markers of prodromal Parkinson disease
Ronald B. Postuma et al.
NATURE REVIEWS NEUROLOGY (2016)
Biomarkers in Parkinson's disease: Advances and strategies
Marion Delenclos et al.
PARKINSONISM & RELATED DISORDERS (2016)
Epidemiology of Parkinson's disease
A. Elbaz et al.
REVUE NEUROLOGIQUE (2016)
Triangulation in aetiological epidemiology
Debbie A. Lawlor et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2016)
Guidelines for reporting methodological challenges and evaluating potential bias in dementia research
Jennifer Weuve et al.
ALZHEIMERS & DEMENTIA (2015)
The potential for prevention of dementia across two decades: the prospective, population-based Rotterdam Study
Renee F. A. G. de Bruijn et al.
BMC MEDICINE (2015)
Olfaction and Aging: A Mini-Review
Johannes Attems et al.
GERONTOLOGY (2015)
Biomarkers of Parkinson's disease: Present and future
Diane B. Miller et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2015)
MDS research criteria for prodromal Parkinson's disease
Daniela Berg et al.
MOVEMENT DISORDERS (2015)
Clinical implications of delayed orthostatic hypotension A 10-year follow-up study
Christopher H. Gibbons et al.
NEUROLOGY (2015)
Epidemiology of neurodegenerative diseases in sub-Saharan Africa: a systematic review
Alain Lekoubou et al.
BMC PUBLIC HEALTH (2014)
Prodromal symptoms and early detection of Parkinson's disease in general practice: a nested case-control study
Annette O. A. Plouvier et al.
FAMILY PRACTICE (2014)
Suspected survivor bias in case-control studies: stratify on survival time and use a negative control
Nienke van Rein et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2014)
PREDICT-PD: Identifying risk of Parkinson's disease in the community: methods and baseline results
Alastair J. Noyce et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)
Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease
Daniela Berg et al.
MOVEMENT DISORDERS (2014)
The PRIPS study: screening battery for subjects at risk for Parkinson's disease
D. Berg et al.
EUROPEAN JOURNAL OF NEUROLOGY (2013)
Gene-environment interactions in Parkinson's disease: Specific evidence in humans and mammalian models
Jason R. Cannon et al.
NEUROBIOLOGY OF DISEASE (2013)
Olfaction and imaging biomarkers in premotor LRRK2 G2019S-associated Parkinson disease
Maria Sierra et al.
NEUROLOGY (2013)
Diagnostic Delay in REM Sleep behavior Disorder (RbD)
Caroline White et al.
JOURNAL OF CLINICAL SLEEP MEDICINE (2012)
Genetic modification of the association of paraquat and Parkinson's disease
Samuel M. Goldman et al.
MOVEMENT DISORDERS (2012)
Defining at-risk populations for Parkinson's disease: Lessons from ongoing studies
Daniela Berg et al.
MOVEMENT DISORDERS (2012)
The significance of defining preclinical or prodromal Parkinson's disease
C. Warren Olanow et al.
MOVEMENT DISORDERS (2012)
Generalizability The trees, the forest, and the low-hanging fruit
Walter A. Kukull et al.
NEUROLOGY (2012)
Age-Specific Progression of Nigrostriatal Dysfunction in Parkinson's Disease
Raul de la Fuente-Fernandez et al.
ANNALS OF NEUROLOGY (2011)
Pre-motor features of Parkinson's disease: the Honolulu-Asia Aging Study experience
G. Webster Ross et al.
PARKINSONISM & RELATED DISORDERS (2011)
The Parkinson Progression Marker Initiative (PPMI)
Kenneth Marek et al.
PROGRESS IN NEUROBIOLOGY (2011)
REM sleep behavior disorder Updated review of the core features, the REM sleep behavior disorder-neurodegenerative disease association, evolving concepts, controversies, and future directions
Bradley F. Boeve
YEAR IN NEUROLOGY 2 (2010)
Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder a prospective study (vol 9, pg 1070, 2010)
A. Iranzo et al.
LANCET NEUROLOGY (2010)
Gene-environment interactions in Parkinson's disease and other forms of parkinsonism
Jeffery M. Vance et al.
NEUROTOXICOLOGY (2010)
Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study
Alex Iranzo et al.
LANCET NEUROLOGY (2010)
Observational Studies Analyzed Like Randomized Experiments An Application to Postmenopausal Hormone Therapy and Coronary Heart Disease
Miguel A. Hernan et al.
EPIDEMIOLOGY (2008)
Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study
Daniel G. Healy et al.
LANCET NEUROLOGY (2008)
Biomarkers for the early detection of Parkinson's and Alzheimer's disease
Daniela Berg
NEURODEGENERATIVE DISEASES (2008)
Evaluation of LRRK2 G2019S penetrance -: Relevance for genetic counseling in Parkinson disease
S. Goldwurm et al.
NEUROLOGY (2007)
The role of early life environmental risk factors in Parkinson disease: what is the evidence?
G Logroscino
ENVIRONMENTAL HEALTH PERSPECTIVES (2005)
Idiopathic hyposmia as a preclinical sign of Parkinson's disease
MM Ponsen et al.
ANNALS OF NEUROLOGY (2004)
Clustering of Parkinson disease - Shared cause or coincidence?
A Kumar et al.
ARCHIVES OF NEUROLOGY (2004)
Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder - Comparison with Parkinson's disease and controls
I Eisensehr et al.
BRAIN (2000)
分享论文
